Boston Scientific Completes Acquisition of Relievant Medsystems, Inc.

Marlborough, MA, November 17, 2023 (PRNewswire) -- Boston Scientific Corporation (NYSE: BSX) announces the completion of its acquisition of Relievant Medsystems Inc., the sole provider of the FDA-cleared Intracept® Intraosseous Nerve Ablation System for treating vertebrogenic pain, a form of chronic low back pain. The Intracept system, a basivertebral nerve ablation therapy, enhances Boston Scientific's chronic pain portfolio, which includes spinal cord stimulation, radiofrequency ablation, and interspinous spacer procedures.

Read full article here.